Physician Resource Center
Featured Content View More
News
Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.
News
Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy
Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.
News
New Research Sheds Light on How Precancerous Lesions Form in the Pancreas
Discoveries about two metabolic enzymes could point the way to biomarkers, opportunities to prevent cancer.
News
Roswell Park Comprehensive Cancer Center is one of only five sites in the U.S. offering a first-in-human clinical trial to gauge the safety and anti-tumor activity of LTZ-301 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL).
News
Clinical study marks SurVaxM’s second phase 2 trial in a major cancer indication
News
Join Roswell Park Experts at ASCO
Nearly two dozen experts from Roswell Park Comprehensive Cancer Center will be attending this year’s American Society of Clinical Oncology conference in Chicago, May 30-June 3, and we’d like to invite you to meet them.
This site is intended for healthcare professionals
RPMD App
Access wherever you go
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
Upcoming Physician & Research Events
Roswell Park Oncology Symposium Quarterly Series Pancreatic Cancer
May 7, 2025 | Buffalo, NY
June 11, 2025 | Buffalo, NY
5th Translational Genomics & Epigenomics Symposium
September 18-19, 2025 | Buffalo, NY
BROADCASTMED